Search results
Texas Company's Mission to Cure Macular Degeneration Blindness
The Joplin Globe· 4 days agoTwenty Million people in America (12% of the population over 40) have Macular Degeneration and Two...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 1 day agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
Home vision tests offer limited diagnostic accuracy for neovascular AMD
Medical Xpress· 5 days agoNo home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics...
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 2 days agoThe paper-based KeepSight Journal from the International Macular and Retinal Foundation, Genentech's...
RevOpsis Welcomes Dr. Emmett Cunningham to Strategic Advisory Board
The Yuma Sun· 1 day agoRevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in...
...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry...
Benzinga· 3 days agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
Scientists find potential treatment target for leading cause of blindness
Investing.com· 2 days agoNew Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular...
Vision-Language Models for Feature Detection of Macular Diseases on Optical Coherence Tomography
Journal of the American Medical Association· 2 days agoThis cross-sectional study evaluates the performance of a vision-language model in performing ophthalmologic tasks related to interpretation of optical coherence tomography scans.
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
KTLA-TV Los Angeles· 3 days agoAt the OIS Retina Innovation...
...Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) -...
WTNH-TV New Haven· 4 days agoEB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental...